000 | 01941 a2200517 4500 | ||
---|---|---|---|
005 | 20250513232932.0 | ||
264 | 0 | _c20010426 | |
008 | 200104s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1006/bbrc.2001.4431 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Nigris, F | |
245 | 0 | 0 |
_ac-myc activation in early coronary lesions in experimental hypercholesterolemia. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cMar 2001 |
||
300 |
_a945-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aAscorbic Acid _xpharmacology |
650 | 0 | 4 | _aBasic-Leucine Zipper Transcription Factors |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aCholesterol, Dietary _xadministration & dosage |
650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
650 | 0 | 4 |
_aDNA-Binding Proteins _xdrug effects |
650 | 0 | 4 |
_aDinoprost _xblood |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
650 | 0 | 4 |
_aProteins _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xdrug effects |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 | _aTranscription Factors |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xdrug effects |
650 | 0 | 4 |
_aVitamin E _xpharmacology |
650 | 0 | 4 | _aGADD45 Proteins |
700 | 1 | _aLerman, L O | |
700 | 1 | _aRodriguez-Porcel, M | |
700 | 1 | _aDe Montis, M P | |
700 | 1 | _aLerman, A | |
700 | 1 | _aNapoli, C | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 281 _gno. 4 _gp. 945-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2001.4431 _zAvailable from publisher's website |
999 |
_c11175065 _d11175065 |